Amphastar Pharmaceuticals (AMPH) Stock Forecast & Price Target

$37.75

-0.81 (-2.10%)

(As of 07/5/2024 08:52 PM ET)

Amphastar Pharmaceuticals - Analysts' Recommendations and Stock Price Forecast (2024)

MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0 to .5 = Strong Sell, .5 to 1 = Sell, 1 to 1.5 = Reduce, 1.5 to 2.5 = Hold, 2.5 to 3.0 = Moderate Buy, 3.0 to 3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.

Consensus Rating

Moderate Buy
Based on 5 Analyst Ratings

Consensus Price Target

$66.00
74.83% Upside

High Forecast	$71.00
Average Forecast	$66.00
Low Forecast	$60.00

Type	Current Forecast 7/9/23 to 7/8/24	1 Month Ago 6/9/23 to 6/8/24	3 Months Ago 4/10/23 to 4/9/24	1 Year Ago 7/9/22 to 7/9/23
Consensus Rating	Moderate Buy	Moderate Buy	Moderate Buy	Buy
Strong Buy	0 Strong Buy rating(s)	0 Strong Buy rating(s)	0 Strong Buy rating(s)	0 Strong Buy rating(s)
Buy	3 Buy rating(s)	2 Buy rating(s)	2 Buy rating(s)	3 Buy rating(s)
Hold	2 Hold rating(s)	2 Hold rating(s)	1 Hold rating(s)	0 Hold rating(s)
Sell	0 Sell rating(s)	0 Sell rating(s)	0 Sell rating(s)	0 Sell rating(s)
Consensus Price Target	$66.00	$66.00	$66.00	$45.00
Forecasted Upside	74.83% Upside	18.16% Upside	18.16% Upside	27.62% Upside

Get Amphastar Pharmaceuticals Upgrade and Downgrade Alerts

Sign-up to receive the latest news and ratings for AMPH and its competitors with MarketBeat's FREE daily newsletter.

Ad Crypto 101 Media

[Urgent] Hedge Funds Expect Major Crypto Moves

In the year following Bitcoin’s last Halving event, that happened in May of 2020… Bitcoin shot up over 550%. But that’s not all…

Click here to register now.

AMPH Analyst Recommendations By Month

The chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.

AMPH Price Targets by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.

Amphastar Pharmaceuticals Stock vs. The Competition

Type	Amphastar Pharmaceuticals	Medical Companies	S&P 500
Consensus Rating Score	2.60	2.71	2.50
Consensus Rating	Moderate Buy	Moderate Buy	Moderate Buy
Predicted Upside	74.83% Upside	1,005.50% Upside	12.25% Upside
News Sentiment Rating	Positive News	Positive News	Positive News

Recent Analyst Forecasts and Stock Ratings

Rating

Upside/Downside

Action

Time Frame

Start Date

End Date

Show

Export to Excel

Date	Brokerage	Action	Rating	Price Target	Upside/Downside on Report Date
6/27/2024	Piper Sandler Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Overweight ➝ Overweight	$71.00 ➝ $71.00	+73.55%
5/22/2024	Needham & Company LLC Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Hold
3/5/2024	JPMorgan Chase & Co. Subscribe to MarketBeat All Access for the recommendation accuracy rating	Initiated Coverage	Overweight	$60.00	+28.53%
11/17/2023	Bank of America Subscribe to MarketBeat All Access for the recommendation accuracy rating	Initiated Coverage	Neutral	$63.00	+12.16%
7/25/2023	Jefferies Financial Group Subscribe to MarketBeat All Access for the recommendation accuracy rating	Initiated Coverage	Buy ➝ Buy	$70.00	+15.36%
7/29/2022	Capital One Financial Subscribe to MarketBeat All Access for the recommendation accuracy rating	Initiated Coverage	Overweight	$44.00	+18.06%

Analyst ratings data on MarketBeat is provided by Benzinga and other data providers. This page was last refreshed on Monday at 08:12 AM ET.

AMPH Forecast - Frequently Asked Questions

What is Amphastar Pharmaceuticals' forecast for 2024?: According to the research reports of 5 Wall Street equities research analysts, the average twelve-month stock price forecast for Amphastar Pharmaceuticals is $66.00, with a high forecast of $71.00 and a low forecast of $60.00.
Should I buy or sell Amphastar Pharmaceuticals stock right now?: 5 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Amphastar Pharmaceuticals in the last twelve months. There are currently 2 hold ratings and 3 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "moderate buy" AMPH shares.
Does Amphastar Pharmaceuticals's stock price have much upside?: According to analysts, Amphastar Pharmaceuticals's stock has a predicted upside of 29.13% based on their 12-month stock forecasts.
What analysts cover Amphastar Pharmaceuticals?: Amphastar Pharmaceuticals has been rated by research analysts at Needham & Company LLC, and Piper Sandler in the past 90 days.
Do Wall Street analysts like Amphastar Pharmaceuticals more than its competitors?: Analysts like Amphastar Pharmaceuticals less than other "medical" companies. The consensus rating score for Amphastar Pharmaceuticals is 2.60 while the average consensus rating score for "medical" companies is 2.71. Learn more on how AMPH compares to other companies.